{"id":9331,"date":"2012-05-07T10:52:05","date_gmt":"2012-05-07T14:52:05","guid":{"rendered":"http:\/\/sciencebusiness.technewslit.com\/?p=9331"},"modified":"2012-05-07T10:52:05","modified_gmt":"2012-05-07T14:52:05","slug":"genomic-test-developed-for-adhd-drug-decisions","status":"publish","type":"post","link":"https:\/\/technewslit.com\/sciencebusiness\/?p=9331","title":{"rendered":"Genomic Test Developed for ADHD Drug Decisions"},"content":{"rendered":"<figure id=\"attachment_1334\" aria-describedby=\"caption-attachment-1334\" style=\"width: 200px\" class=\"wp-caption alignleft\"><a href=\"http:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/10\/Brain_NIH.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-1334\" title=\"Brain_NIH\" src=\"http:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/10\/Brain_NIH.jpg\" alt=\"Illustration of brain (NIDA)\" width=\"200\" height=\"199\" srcset=\"https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/10\/Brain_NIH.jpg 200w, https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/10\/Brain_NIH-150x149.jpg 150w\" sizes=\"auto, (max-width: 200px) 100vw, 200px\" \/><\/a><figcaption id=\"caption-attachment-1334\" class=\"wp-caption-text\">(National Institute of Drug Abuse)<\/figcaption><\/figure>\n<p><a href=\"http:\/\/www.assurerxhealth.com\/index.php?id=232\">AssureRx Health Inc.<\/a> in Mason, Ohio has developed a test to help clinicians prescribe the appropriate medications for patients &#8212; both children and adults &#8212; with attention deficit hyperactivity disorder (ADHD). The test, called GeneSightRx ADHD, gauges genomic differences in the way different patients would tolerate ADHD medications.<\/p>\n<p>Understanding a patient&#8217;s unique genomic composition may help a clinician prescribe a patient&#8217;s precise selection of drugs and minimize the chance for side effects that can occur with these medications. The GeneSightRx ADHD test analyzes variations in three genes that influence how a patient might metabolize certain medications used to treat ADHD in children and adults. AssureRx Health says the analysis is based on FDA-approved manufacturer&#8217;s drug labels and published research on pharmacogenomics &#8212; the influence of genetics on drug response.<\/p>\n<p>The test involves taking a DNA sample from the patient with a non-invasive cheek swab. The specimen is sent overnight to AssureRx Health&#8217;s lab, which conducts the analysis. The clinician then receives the patient report through a secure online portal.<\/p>\n<p>According to <a href=\"http:\/\/www.nimh.nih.gov\/health\/topics\/attention-deficit-hyperactivity-disorder-adhd\/index.shtml\">National Institute of Mental Health<\/a>, ADHD is one of the most common childhood disorders and can continue through adolescence and adulthood. Symptoms include difficulty staying focused and paying attention, difficulty controlling behavior, and hyperactivity (over-activity). The <a href=\"http:\/\/www.cdc.gov\/ncbddd\/adhd\/data.html\">Centers for Disease Control and Prevention<\/a> cites surveys of parents that estimate 9.5 percent of children age 4 to 17 have been diagnosed the ADHD as of 2007, with diagnosis increasing by 22 percent between 2003 and 2007.<\/p>\n<p>Read more:\u00a0<a href=\"http:\/\/sciencebusiness.technewslit.com\/?p=8714\">Trial Underway for Non-Addictive ADHD Drug for Adults<\/a><\/p>\n<p style=\"text-align: center;\">*\u00a0\u00a0\u00a0\u00a0 *\u00a0\u00a0\u00a0\u00a0 *<\/p>\n","protected":false},"excerpt":{"rendered":"<p>AssureRx Health Inc. in Mason, Ohio has developed a test to help clinicians prescribe the appropriate medications for patients &#8212; both children and adults &#8212; with attention deficit hyperactivity disorder (ADHD). The test, called GeneSightRx ADHD, gauges genomic differences in the way different patients would tolerate ADHD medications. Understanding a patient&#8217;s unique genomic composition may [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[31,55,64,77,27],"class_list":["post-9331","post","type-post","status-publish","format-standard","hentry","category-products","tag-biomedical","tag-genomics","tag-life-sciences","tag-medical-device","tag-pharmaceuticals"],"_links":{"self":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/9331","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=9331"}],"version-history":[{"count":3,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/9331\/revisions"}],"predecessor-version":[{"id":9334,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/9331\/revisions\/9334"}],"wp:attachment":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=9331"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=9331"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=9331"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}